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STUDY QUESTION: Can markers of human endometrial hypoxia be detected at menstruation in vivo?
SUMMARY ANSWER: Our in vivo data support the presence of hypoxia in menstrual endometrium of women during physiological
menstruation.
WHAT IS KNOWN ALREADY: Current evidence from animal models and human in vitro studies suggests endometrial hypoxia is
present at menstruation and drives endometrial repair post menses. However, detection of human endometrial hypoxia in vivo remains
elusive.
STUDY DESIGN, SIZE, DURATION: We performed a prospective case study of 16 women with normal menstrual bleeding.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Reproductively aged female participants with a regular menstrual cycle
underwent objective measurement of their menstrual blood loss using the alkaline haematin method to confirm a loss of <80 ml per cycle.
Exclusion criteria were exogenous hormone use, an intrauterine device, endometriosis or fibroids >3 cm. Participants attended for two
MRI scans; during days 1–3 of menstruation and the early/mid-secretory phase of their cycle. The MRI protocol included dynamic
contrast-enhanced MRI and T2* quantification. At each visit, an endometrial sample was also collected and hypoxia-regulated repair factor
mRNA levels (ADM, VEGFA, CXCR4) were quantified by RT-qPCR.
MAIN RESULTS AND THE ROLE OF CHANCE: Women had reduced T2* during menstrual scans versus non-menstrual scans
(P¼ 0.005), consistent with menstrual hypoxia. Plasma flow (Fp) was increased at menstruation compared to the non-menstrual phase
(P¼ 0.0005). Laboratory findings revealed increased ADM, VEGF-A and CXCR4 at menstruation on examination of paired endometrial
biopsies from the menstrual and non-menstrual phase (P¼ 0.008; P¼ 0.03; P¼ 0.009). There was a significant correlation between T2*
and these ex vivo hypoxic markers (P< 0.05).
LIMITATIONS, REASONS FOR CAUTION: This study examined the in vivo detection of endometrial hypoxic markers at
specific timepoints in the menstrual cycle in women with a menstrual blood loss <80 ml/cycle and without significant uterine structural
abnormalities. Further research is required to determine the presence of endometrial hypoxia in those experiencing abnormal uterine
bleeding with and without fibroids/adenomyosis.
WIDER IMPLICATIONS OF THE FINDINGS: Heavy menstrual bleeding (HMB) is a common, debilitating condition. Understanding
menstrual physiology may improve therapeutics. To our knowledge, this is the first in vivo data supporting the presence of menstrual
hypoxia in the endometrium of women with normal menstrual bleeding. If aberrant in those with HMB, these non-invasive tests may aid
diagnosis and facilitate personalized treatments for HMB.
STUDY FUNDING/COMPETING INTEREST(S): This work was funded by Wellbeing of Women grant RG1820, Wellcome Trust
Fellowship 209589/Z/17/Z and undertaken in the MRC Centre for Reproductive Health, funded by grants G1002033 and
MR/N022556/1. H.O.D.C. has clinical research support for laboratory consumables and staff from Bayer AG and provides consultancy
VC The Author(s) 2021. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted
reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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Introduction
Heavy menstrual bleeding (HMB) affects 20–30% of pre-menopausal
women causing decreases in physical, psychological, economic and
social health (RCOG, 2011). Medical treatments are available but are
often discontinued due to lack of efficacy or side effects. A national
4-year audit of HMB in the UK reported that 43% of women received
surgery in the year following first attendance at hospital (RCOG,
2011). Surgery usually ends fertility and introduces the risk of organ
damage, haemorrhage and infection. Delineation of the physiology
of menstrual initiation and cessation is required to identify effective
diagnostic and personalized therapeutic strategies for this debilitating
symptom.
Progesterone levels decline in the late secretory phase of the
menstrual cycle due to corpus luteal regression. This causes an influx
of inflammatory mediators to the local endometrial environment,
including potent vasoconstrictors, e.g. prostaglandin-F2a and
endothelin-1 (Smith et al., 1981; Marsh et al., 1997). This ‘injury’ leads
to bleeding and shedding of the functional endometrial layer during
menstruation. The endometrium then undergoes re-epithelialization
and stromal expansion in an efficient ‘repair’ phase to maintain func-
tion (i.e. receptivity) in the subsequent cycle (Critchley et al., 2020).
Hypoxia arises when the metabolic oxygen demand of a tissue
exceeds its supply and is usually defined as a partial pressure of less
than 10 mmHg (Hockel and Vaupel, 2001). The presence and role of
hypoxia during human endometrial breakdown and repair remains
controversial. Its presence during menstruation was first suggested
80 years ago. Endometrial explants transplanted into the anterior
chamber of the eye in the rhesus monkey revealed that progesterone
withdrawal was followed by intense vasoconstriction, tissue necrosis
and bleeding (Markee, 1940). Endometrial hypoxia has been confirmed
during menstruation in the mouse model of simulated menses using
pimonidazole, a marker of oxygen levels <10 mmHg (Fan et al., 2008;
Cousins et al., 2016; Maybin et al., 2018). However, xenograft studies
in mice failed to detect hypoxia in human endometrial explants during
endometrial breakdown or repair (Coudyzer et al., 2013).
Our human ex vivo studies have revealed that hypoxia-inducible
factor (HIF)-1a and its downstream targets can be detected in human
endometrial biopsies, exclusively during the peri-menstrual phase, with
a distinct reduction when bleeding has ended (Critchley et al., 2006;
Maybin et al., 2018). HIF-1a is rapidly degraded in normoxia and is
the master regulator of the hypoxic response, hence its presence is
consistent with a local tissue hypoxia in the endometrium during
menstruation.
In vitro, progesterone withdrawal and hypoxia are necessary for in-
duction of putative repair factors in the human endometrial explants,
e.g. vascular endothelial growth factor (VEGF). The hypoxic induction
of these factors was dependent upon HIF-1a (Maybin et al., 2011a,c).
We hypothesize that endometrial hypoxia is present in women during
physiological menstruation to drive the repair process and limit men-
strual blood loss.
Accurate determination of human endometrial perfusion and hyp-
oxia in vivo has not been possible to date. Non-invasive magnetic reso-
nance techniques have been used to investigate markers of tissue
hypoxia at other tissue sites (Punwani et al., 1998; Prasad and Epstein,
1999; Jordan et al., 2004; Nielsen et al., 2004; dos Santos et al., 2007).
T2* is a characteristic tissue relaxation time. It depends on inhomoge-
neities in the main magnetic field produced by the scanner as well as
inhomogeneities induced by the presence of other nearby molecules
such as deoxyhaemoglobin, a marker of tissue oxygenation (Ogawa
et al., 1990). The presence of paramagnetic deoxyhaemoglobin within
red blood cells increases their magnetic susceptibility, creating local
magnetic field gradients around the cells (Thulborn et al., 1982) which
results in a reduction in T2* (Jezzard et al., 2003). This technique has
been widely applied in both pre-clinical and clinical studies to evaluate
tissue oxygenation status in organs including the kidney (Prasad and
Epstein, 1999; dos Santos et al., 2007), brain (Punwani et al., 1998)
and muscle (Jordan et al., 2004).
Dynamic contrast-enhanced MRI (DCE-MRI) enables quantitative
estimation of tissue perfusion parameters. It analyses the temporal
enhancement of a tissue after a paramagnetic (gadolinium-based) con-
trast agent is injected intravascularly. These images allow quantification
of parameters such as vascular plasma volume (vp), plasma flow
(Fp), extraction fraction (E) and permeability surface area product (PS).
This technique has been used to investigate tissue perfusion in the
breast (Kuhl et al., 1999), prostate (Preziosi et al., 2003), heart
(Nielsen et al., 2004) and liver (Patel et al., 2010). We propose that
these magnetic resonance techniques could be applied to investigate
endometrial perfusion and hypoxia non-invasively.
The objective of this study was to determine if endometrial hypoxia
can be detected in vivo using MRI. Herein, we describe the use of T2*
quantification and DCE-MRI to determine the presence of markers of




A favourable ethical opinion for these studies was obtained from the
West of Scotland Research Ethics Committee (REC 15/WS/0212).
Recruitment
Women of reproductive age (18–55 years) with regular menstrual
cycles (21–35 days) were invited to participate. Women with exoge-
nous hormone or intrauterine device use in the two months prior to
recruitment and those with known endometriosis or fibroids >3 cm
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were excluded. Written informed consent was obtained from
31 women (Supplementary Fig. S1). Three women withdrew from the
study and four became ineligible (one woman became pregnant, one
woman commenced fertility treatment and two women entered the
peri-menopause with onset of menstrual cycle irregularity). Therefore,
24 participants underwent objective measurement of their menstrual
blood loss using the alkaline haematin method (Hallberg and Nilsson,
1964). Sixteen women had an objective blood loss of <80 ml
and were included in the study. These participants were invited to
attend for two MRI scans, one in the menstrual phase of their cycle
(Days 1–3) and the other timed for the early/mid-secretory phase.
Further confirmatory evidence of correct cycle stage was provided by
(i) serum blood sample for measurement of circulating oestradiol and
progesterone concentrations and (ii) endometrial histological appear-
ance (Noyes et al., 1950) in women who also had an endometrial
biopsy collected. Participant characteristics and hormone levels are
detailed in Supplementary Table SI.
MRI assessment
Each participant was imaged supine at 3T (Siemens Magnetom Verio or
Skyrafit, Siemens Healthineers, Erlangen, Germany), once during the
menstrual phase (Days 1–3) and once during the early/mid-secretory
phase of their cycle. Prior to imaging, 20 mg hyoscine butylbromide was
administered intravenously in order to minimize bowel peristalsis and
improve image quality. Images were acquired using the 32-channel
(Verio) or 60-channel body array (Skyrafit). Fourteen women completed
two scans, one woman did not attend a second scan and one woman
had a non-menstrual sample classified as ‘disordered proliferative’ and
was excluded from analysis. Of the 14 women who completed two
scans, two women were unable to complete the full protocol (n¼ 1
had T2* quantification only and n¼ 1 underwent DCE-MRI only).
T2*
For quantification of T2*, a single slice multiecho gradient echo in the
axial and coronal planes (Siemens MyoMaps) was used (sequence
parameters are detailed in Supplementary Table SII). Regions of interest
(ROI) for the endometrium and uterus (excluding the cervix) were de-
lineated using OsiriX. The axial and coronal T2* images were examined
with reference to structural T2-weighted (T2w) sagittal, coronal and ax-
ial images (TSE, Turbo Spin Echo) (Fig. 1a–c) to help clearly delineate
the ROI (Fig. 1e and f). T2* mean and standard deviation were calcu-
lated for each ROI. When ROIs for both planes in the T2* images
were able to be obtained, the T2* value from the plane which had a
lower standard deviation was selected. In some planes for the T2*
images, the ROI could not be clearly delineated due to poor resolution.
If this occurred then the same planes were used across the two scans
for the participant when possible (i.e. coronal, coronal or axial, axial).
DCE-MRI
The perfusion imaging protocol included IR-TrueFISP (inversion recov-
ery true fast imaging with steady-state precession) for T1 measure-
ment and a sagittal dynamic 3D FLASH (fast low angle shot) which
was acquired during injection of 0.1 mg/kg Gadovist followed by 20 ml
saline chaser at 2 ml/s. The sequence parameters used are in
Supplementary Table SII. T1 maps were calculated using in-house
software (Python 3.6) by fitting a standard inversion recovery curve to
the IR-TrueFISP data. This was then used to convert signal intensity to
contrast agent concentration (CA) in the dynamic images. The two-
compartment uptake model (de Bazelaire et al., 2005; Ingrisch and
Sourbron, 2013) was fitted to concentration versus time curves on a
voxel-by-voxel basis, using arterial input functions derived at each visit
from the common iliac arteries. In this model, the CA is assumed to
be distributed between two compartments: the plasma (vascular)
space (vp) and the extravascular extracellular space (EES). The CA is
delivered to the plasma space via the arteries at a rate depending on
the Fp. A fraction of the CA diffuses into the EES at a rate depending
on the permeability and surface area of the capillary walls (PS). In the
two-compartment uptake model, the assumption is made that the
backflow of CA from the EES to the plasma space is negligible. This
model was fitted for Fp, vp and E which is the fraction of CA extracted
from the plasma into the EES in the first pass. E is related to PS via the
equation E ¼ PS/(PS þ Fp) (Sourbron and Buckley, 2011).
OsiriX was used to draw ROIs for the endometrium and uterus
(excluding the cervix) on the high resolution sagittal T2w images.
These ROIs were then transferred to the lower resolution dynamic se-
ries images with adjustments if required (Fig. 1d). Mean values and
standard deviations of Fp, E and vp for the uterus and endometrium
were extracted from calculated parameter maps using the pyOsiriX
plugin (Blackledge et al., 2016).
Tissue collection
Endometrial biopsies were collected with an endometrial suction cu-
rette (Pipelle, Laboratoire CCD, Paris, France) and immediately di-
vided and placed in (i) RNA later (Ambion (Europe) Ltd., Warrington,
UK) prior to storage at 80C and (ii) 4% (v/v) formaldehyde (10%
neutral buffered formalin) prior to paraffin embedding. Tissue was
dated according to three criteria: (i) histological appearance (Noyes
et al., 1950) assessed by a consultant pathologist (ii) serum levels of
oestradiol and progesterone at time of biopsy and (iii) date of the par-
ticipant’s last menstrual period. Of the 16 women who participated,
five women wished for a single endometrial biopsy only, two women
declined an endometrial biopsy and in one woman it was not possible
to obtain an endometrial sample. Therefore, eight women had paired
endometrial samples in the menstrual and non-menstrual phase (prolif-
erative n¼ 1; early/mid-secretory n¼ 7) (Supplementary Fig. S1).
Real-time quantitative reverse transcription
PCR
Total RNA from human endometrium samples was extracted using
the RNeasy Mini Kit (Qiagen Ltd, Sussex, UK) according to manufac-
turer’s instructions. RNA samples (100 ng) were reverse transcribed
using iScript cDNA synthesis kit (Bio-Rad Laboratories Ltd, UK) along-
side control samples. Specific primers were designed using the univer-
sal probe library assay design centre and checked with BLAST
(Supplementary Table SIII). All primers were validated before use to
ensure efficiency was 90–100%. Samples were analysed in triplicate us-
ing ABI QuantStudio system. The comparative 2-DDCt method was
used to analyse genes of interest. Normalization to the geometric
mean of the reference genes (SDHA and ATP5B) was performed be-
fore comparison to a positive calibrator sample (liver cDNA). These
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reference genes were determined using the geNorm assay and shown
to be stable across stage of menstrual cycle.
Statistical analysis
Statistical analysis was performed using GraphPad Prism Software
(GraphPad Prism Software, Inc., San Diego, CA, USA). Paired t-tests
(normally distributed data) or the Wilcoxon signed-rank test (non-
parametric data) was used to analyse differences in MRI quantification
and PCR values between menstrual and non-menstrual cycle stages.
Correlation between MRI and laboratory detection of hypoxic markers
was determined using the Spearman’s rank correlation test. A value of
P< 0.05 was considered statistically significant.
Results
Endometrial T2* was significantly lower at
menstruation versus non-menstrual time-
points, consistent with the presence of en-
dometrial hypoxia at menses
Endometrial T2* was quantified in 13 participants with confirmed
normal menstrual bleeding (<80 ml) during the menstrual phase (Days
1–3) and a non-menstrual timepoint (n¼ 12 early/mid-secretory,
n¼ 1 proliferative). Endometrial T2* was significantly lower in the
menstrual phase compared to the non-menstrual phase (P¼ 0.005)
consistent with the presence of endometrial hypoxia at menses
(Fig. 2).
Endometrial plasma flow was significantly
higher at menstruation versus non-
menstrual timepoints
DCE-MRI analysis was completed on 12 paired visits (as one
participant was excluded from final analysis due to non-physiological
Fp values). Endometrial Fp was significantly higher in the menstrual
Figure 1. Example images and regions of interest. Top row: T2-weighted (T2w) structural images in the sagittal (a), coronal (b) and axial
planes (c), slice locations matching bottom row images for easy reference during outlining. Bottom row: Dynamic contrast-enhanced image (d) show-
ing outlined endometrium (white) and uterus (green). T2* maps in the coronal (e) and axial (f) planes with endometrium and uterus outlined.
Figure 2. Endometrial T2* was significantly lower at
menstruation than during the non-menstrual phase, consis-
tent with menstrual endometrial hypoxia. n¼ 13 women
scanned on two visits. **P< 0.01.
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..phase compared to the non-menstrual phase (P< 0.001) (Fig. 3a).
Endometrial E was significantly lower at menstruation compared to the
non-menstrual phase (P< 0.001) (Fig. 3b). There was no difference in
endometrial vp between these two cycle phases (P¼ 0.05) (Fig. 3c).
To further interpret the significant decrease in endometrial E at
menstruation, the PS was calculated and compared. No difference in
endometrial PS between the two cycle phases was seen (P¼ 0.06)
(Fig. 3d). Therefore, the difference in E is driven by the change in flow
(Fp) rather than a change in vessel permeability between different cy-
cle stages.
Ex vivo hypoxic markers were significantly
higher in human menstrual endometrium
compared with endometrium when not
menstruating
RNA was extracted from whole endometrial tissue and HIF-1 regu-
lated genes quantified using RT-qPCR. Analysis was performed on
eight paired menstrual and non-menstrual samples. There were signifi-
cantly higher levels of ADM, VEGF-A and CXCR4 in menstrual com-
pared to non-menstrual endometrium (P< 0.01, P< 0.05, P< 0.01,
respectively) (Fig. 4a–c).
The significant negative correlation
between T2* values and RT-qPCR concen-
trations of endometrial hypoxia-regulated
genes highlight the potential of MRI as a
tool to detect endometrial hypoxia in vivo
To validate T2* quantification as a non-invasive technique for assessing
endometrial hypoxia, Spearman’s rank correlation was performed be-
tween T2* and ADM/VEGF-A and CXCR4 mRNA levels in menstrual
and non-menstrual endometrium from women with normal menstrual
bleeding. A significant negative correlation was seen between T2* and
the concentrations of these hypoxia-regulated genes (P< 0.05)
(Fig. 5a–c).
Figure 3. Endometrial plasma flow (Fp) was significantly higher at menstruation than during the non-menstrual phase.
(a) Endometrial Fp at menstruation and the non-menstrual phase. (b) Endometrial extraction fraction (E) at menstruation and the non-menstrual
phase. (c) Endometrial plasma volume (vp) at menstruation and the non-menstrual phase. (d) Endometrial permeability surface area product (PS) at
menstruation and the non-menstrual phase. n¼ 13 women scanned on two visits; ns, not significant; ***P< 0.001.
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Figure 4. Ex vivo hypoxia markers were significantly
higher in menstrual versus non-menstrual endometrium.
(a) Endometrial ADM mRNA levels at menstruation and the non-
menstrual phase. (b) Endometrial VEGF-A mRNA levels at menstrua-
tion and the non-menstrual phase. (c) Endometrial CXCR4 mRNA
levels at menstruation and the non-menstrual phase. n¼ 8 paired
biopsies; *P< 0.05; **P< 0.01.
Figure 5. Endometrial T2* is significantly correlated with
endometrial concentrations of hypoxia-regulated genes
(a: ADM; b: VEGF-A and c: CXCR4) indicating a potential
role in non-invasive detection of endometrial hypoxia. n¼ 8
paired biopsies/T2*; *P< 0.05; **P< 0.01.
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Here, we report that women with normal menstrual bleeding have sig-
nificantly altered MRI parameters during menstruation compared to
those detected during non-menstrual phases of the cycle. T2* values
were significantly decreased during menstruation, consistent with in-
creased deoxyhaemoglobin and tissue hypoxia at menses. Endometrial
plasma flow was significantly increased during menstruation, whereas
extraction fraction was decreased and plasma volume was not differ-
ent to non-menstrual values. Ex vivo detection of downstream targets
of HIF-1 were significantly increased in menstrual versus non-menstrual
endometrial tissue, consistent with menstrual endometrial hypoxia.
To our knowledge, these data are the first to report endometrial
T2* at two different time points of the menstrual cycle. T2* quantifi-
cation has previously been reported in healthy uterine myometrium
across the cycle (Kido et al., 2007; Imaoka et al., 2012). The junc-
tional zone of the myometrium, located adjacent to the endome-
trium, was found to have a lower T2* value than the outer
myometrium (Kido et al., 2007; Imaoka et al., 2012). This may be sec-
ondary to physiological uterine contractions and peristalsis within the
subendometrial junctional zone (Nakai et al., 2003), resulting in in-
creased deoxyhaemoglobin. Furthermore, consistent with our findings
in the endometrium, the T2* value of both the junctional zone and
the outer myometrium were lower in the menstrual phase compared
to values throughout the rest of the cycle (Kido et al., 2007), which
may be secondary to reduced uterine myometrial perfusion during
menstruation.
A number of other paramagnetic substances, e.g. ferritin and hae-
mosiderin, can cause a change in the local magnetic field and may af-
fect T2*. The presence of ferritin in human endometrial samples has
been investigated previously by immunohistochemistry (Tsionou et al.,
1991). Ferritin was not detected in benign endometrial samples but
was present in endometrial hyperplasia and carcinoma samples
(Tsionou et al., 1991). Menstrual endometrial fragments have been
used to induce endometriosis in mice (Van Langendonckt et al., 2004).
This study found that, prior to injection, the majority of menstrual en-
dometrial fragments were negative for Prussian blue (a stain that
detects ferritin). Therefore, it is unlikely that ferritin contributes to the
changes in T2* seen in this study. Haemosiderin, an iron storage com-
plex, has been detected in the endometrium of women using intra-
uterine levonorgestrel devices (Phillips et al., 2003) but does not occur
in normal, cycling endometrium as the tissue sloughs during menstrua-
tion (Murdock et al., 2019). Haemosiderin deposition is a feature of
chronic bleeding rather than the acute bleeding of normal menstrual
endometrial breakdown. Finally, brain imaging also uses T2* to evalu-
ate intracranial haematomas. Following acute haemorrhage, oxyhae-
moglobin is progressively deoxygenated. At 12–48 h following acute
bleeding, deoxyhaemoglobin is predominant within the haematoma
(Kidwell and Wintermark, 2008). In contrast to haematoma formation,
menstrual bleeding is a dynamic process with tissue shedding and then
passing through the cervix. There is evidence that levels of plasmino-
gen activator increase pre-menstrually (Casslen and Astedt, 1981) to
prevent clot organization and enable tissue fragments to pass through
the cervical os. Therefore, we believe it is unlikely that the T2*
changes demonstrated were due to the presence of old blood within
the uterine cavity at menstruation. Hence, we propose our finding of
reduced T2* at menstruation is consistent with endometrial hypoxia.
Our DCE-MRI findings were unexpected as we hypothesized that
vasoconstriction of endometrial vessels at menstruation would reduce
plasma flow and volume. Support for vasoconstriction following pro-
gesterone withdrawal comes from a number of human studies.
Administration of mifepristone (an anti-progestin) in the secretory
phase of the cycle resulted in subsequent increased immunoreactivity
for COX-2 (Hapangama et al., 2002), the enzyme responsible for the
synthesis of the vasoconstrictor prostaglandin-F2a. A further study ad-
ministering mifepristone to women in the secretory phase found this
resulted in decreased lumen area of the endometrial capillaries, consis-
tent with reduced blood flow (Johannisson et al., 1989). In the classical
experiments by Markee (1940), vasoconstriction of the Rhesus ma-
caque spiral arterioles was also observed following progesterone with-
drawal. However, importantly this was seen to occur prior to
menstruation. Therefore, we propose that endometrial spiral arteriole
vasoconstriction may occur transiently in the late secretory phase and
this constriction has resolved by days 1–3 of the cycle. Hence, instead
of capturing spiral arteriole vasoconstriction, we may have detected
the subsequent perfusion changes in the endometrium during our im-
aging window. Reactive hyperaemia is the temporary increase in tissue
blood flow that occurs to restore tissue oxygen levels following a pe-
riod of oxygen deprivation (Bliss, 1998). The increase in plasma flow
that we detected at menstruation may reflect reactive hyperaemia due
to the physiological mechanism of ‘hypoxic vasodilation’ (Roy and
Brown, 1880; Heistad and Wheeler, 1970; Rowell and Blackmon,
1989). This prompt vascular response increases perfusion of blood to
oxygen-deprived tissues and has been well described in cerebral ves-
sels (Milledge and Sorensen, 1972; Wilson et al., 2011; Willie et al.,
2012), the coronary circulation (Herrmann and Feigl, 1992; Martinez
et al., 2005) and skeletal muscle vascular beds (Black and Roddie,
1958; Halliwill, 2003). Future DCE-MRI studies should focus on the
late secretory phase to determine if endometrial perfusion is de-
creased prior to the onset of active bleeding.
We demonstrate a significant increase in hypoxia-regulated factors
ADM, VEGF-A and CXCR4 at menstruation. A number of previous stud-
ies investigating putative endometrial repair factors with known HIF-
response elements (e.g. CXCR4, CXCL12, ADM) across the menstrual
cycle are limited by their lack of inclusion of menstrual endometrium
(Shifren et al., 1996; Laoag-Fernandez et al., 2000; Laird et al., 2011).
Published gene expression datasets do not enable comparison of
hypoxia-regulated genes between menstrual and secretory endome-
trium in those with normal menstrual blood loss (Ponnampalam et al.,
2004; Girling et al., 2017; Wang et al., 2020). However, consistent
with our findings herein, there is existing evidence that ADM, VEGF and
CXCR4 mRNA levels are significantly up-regulated in the human endo-
metrium at menstruation (Maybin et al., 2011a,c; 2018) and that men-
strual endometrial stromal cells from the functional layer may
contribute to the repair process (Gaide Chevronnay et al., 2009). To
our knowledge, our data are the first to demonstrate increased men-
strual hypoxia-regulated genes in the endometrium using the more ro-
bust methodology of paired samples from the same woman at two
stages of the menstrual cycle.
A significant negative correlation between T2* and ADM/VEGF-A/
CXCR4 was shown, providing further support for T2* quantification as
a non-invasive technique to detect markers of endometrial hypoxia.
T2* quantification has been widely used to investigate tissue oxygena-
tion in the kidney (Prasad and Epstein, 1999; dos Santos et al., 2007),
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brain (Ogawa et al., 1990; Punwani et al., 1998), muscle (Jordan et al.,
2004) and prostate (Hoskin et al., 2007; Chopra et al., 2009). A close
correlation has previously been demonstrated between T2* and the
hypoxic marker pimonidazole (McPhail and Robinson, 2010) along
with oxygen levels measured using a fibre-optic probe (dos Santos
et al., 2007), needle electrode (Chopra et al., 2009) and near-infrared
spectroscopy (Punwani et al., 1998). We believe the data presented
herein are the first to support T2* quantification for detection of hyp-
oxia in the human endometrium. This highlights the potential of this
technique to assess the hypoxic response in the human endometrium
at menstruation non-invasively and may present a novel diagnostic test
for aberrant hypoxia at menstruation.
Although physiological oxygen tensions vary across tissues, the ma-
jority of human end organ tissues are not hypoxic (<10 mmHg).
Reported oxygen tensions in normal human tissue range from the
lower end in muscle (29 mmHg) and brain (35 mmHg) to higher oxy-
gen tensions in liver (41 mmHg) and intestinal tissue (58 mmHg) (Koh
and Powis, 2012). The actual oxygen tension at the human endome-
trial surface during menstruation is unknown. To date, studies have in-
vestigated this only in non-menstrual endometrium. One study used a
fibre-optic microsensor to measure oxygen tension at the endometrial
surface in women just prior to intrauterine insemination (on cycle day
11-18) and found an average oxygen tension of 18.9 mmHg (Ottosen
et al., 2006). This was in keeping with an earlier study using an oxygen
microelectrode that recorded an average endometrial oxygen tension
of 15 mmHg across the proliferative, ovulatory and secretory phase
(Yedwab et al., 1976). These results from non-menstrual endometrium
suggest that with spiral arteriole vasoconstriction, occurring just prior
to menstruation, it is possible that the oxygen tension may fall below
10 mmHg in menstrual endometrium.
An aberrant hypoxic response at menstruation may contribute to
HMB of endometrial origin, i.e. those with no anatomical abnormalities
or systemic disorders and regular menstrual cycles (Munro et al.,
2018). There is evidence that women with HMB have reduced peri-
menstrual endometrial expression of vasoconstrictors, such as
endothelin-1 and prostaglandins (Maybin and Critchley, 2011). As the
radius of a vessel is the major determinant of resistance to flow, de-
creased constriction of endometrial vessels at menstruation will con-
tribute significantly to HMB (Maybin et al., 2011b). Lack of
vasoconstriction during menstruation will also prevent peri-menstrual
hypoxia in the endometrium of women with HMB. Our previous stud-
ies have detected decreased HIF-1a protein and its downstream tar-
gets in the menstrual endometrium of women with HMB (Maybin
et al., 2018). Furthermore, using our mouse model of simulated men-
struation, we have novel in vivo data demonstrating that pharmacologi-
cal inhibition of HIF-1a during menses resulted in delayed re-
epithelialization and stromal restoration and its stabilization leads to ac-
celerated repair (Maybin et al., 2018). Therefore, future studies using
these MRI techniques require inclusion of women with HMB to deter-
mine if they can be used to non-invasively detect aberrant endometrial
hypoxia in vivo.
In summary, our results have identified altered MRI parameters in
the menstrual endometrium of women with normal menstrual blood
loss that are consistent with endometrial hypoxia at menses. These
techniques have the potential to diagnose aberrant physiological hyp-
oxia at menstruation to facilitate precise treatment strategies for those
with problematic menstrual bleeding.
Supplementary data
Supplementary data are available at Human Reproduction online.
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